JY
MRVI icon

Jeff Yass’s Maravai LifeSciences MRVI Stock Holding History

Jeff Yass’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Sell
75,400
-196,600
-72% -$849K ﹤0.01% 10058
2026
Q1 		$770K Buy
+272,000
New +$922K ﹤0.01% 8573
2025
Q3 		– Sell
-25,000
Closed -$60.3K – 13348
2025
Q2 		$60.3K Sell
25,000
-110,500
-82% -$232K ﹤0.01% 12051
2025
Q1 		$299K Buy
135,500
+118,000
+674% +$466K ﹤0.01% 10073
2024
Q4 		$95.4K Buy
17,500
+3,400
+24% +$21.9K ﹤0.01% 11377
2024
Q3 		$117K Buy
+14,100
New +$122K ﹤0.01% 10938
2024
Q2 		– Sell
-125,200
Closed -$1.09M – 12808
2024
Q1 		$1.09M Sell
125,200
-66,700
-35% -$451K ﹤0.01% 6700
2023
Q4 		$1.26M Buy
191,900
+121,700
+173% +$786K ﹤0.01% 6423
2023
Q3 		$702K Sell
70,200
-125,000
-64% -$1.37M ﹤0.01% 7441
2023
Q2 		$2.43M Buy
195,200
+183,500
+1,568% +$2.48M ﹤0.01% 4752
2023
Q1 		$164K Sell
11,700
-20,800
-64% -$299K ﹤0.01% 10827
2022
Q4 		$465K Buy
+32,500
New +$512K ﹤0.01% 8063
2022
Q2 		– Sell
-40,200
Closed -$1.42M – 13566
2022
Q1 		$1.42M Sell
40,200
-12,900
-24% -$432K ﹤0.01% 6278
2021
Q4 		$2.23M Sell
53,100
-10,200
-16% -$413K ﹤0.01% 5263
2021
Q3 		$3.11M Buy
63,300
+36,300
+134% +$1.77M ﹤0.01% 4882
2021
Q2 		$1.13M Sell
27,000
-23,300
-46% -$903K ﹤0.01% 7437
2021
Q1 		$1.79M Buy
50,300
+38,600
+330% +$1.28M ﹤0.01% 6189
2020
Q4 		$328K Buy
+11,700
New +$326K ﹤0.01% 9097

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Jeff Yass's MRVI Position: Q2 2026 in Review

Jeff Yass reduced its Maravai LifeSciences (MRVI) stake by 69% in Q2 2026, selling an estimated $557K and leaving 57,593 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #10652.

Jeff Yass first reported a position in MRVI in Q1 2021 and has held it in 21 quarters since. The position peaked at $30.3M in Q2 2023. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Jeff Yass held 57,593 shares of Maravai LifeSciences worth $359K as of Q2 2026.
  • Jeff Yass sold 129,046 Maravai LifeSciences shares in Q2 2026, an estimated $557K.
  • Maravai LifeSciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10652 holding.
  • Jeff Yass first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 21 quarters since.
  • Jeff Yass's Maravai LifeSciences position peaked at $30.3M in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.